Wall Street brokerages expect that Anthem Inc (NYSE:ANTM) will report earnings per share of $3.90 for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for Anthem’s earnings. The highest EPS estimate is $4.07 and the lowest is $3.83. Anthem posted earnings per share of $2.44 in the same quarter last year, which would indicate a positive year-over-year growth rate of 59.8%. The company is scheduled to report its next earnings report before the market opens on Wednesday, January 29th.
On average, analysts expect that Anthem will report full year earnings of $19.43 per share for the current year, with EPS estimates ranging from $19.37 to $19.45. For the next financial year, analysts anticipate that the business will report earnings of $22.70 per share, with EPS estimates ranging from $22.49 to $23.13. Zacks’ EPS averages are an average based on a survey of sell-side research firms that cover Anthem.
Anthem (NYSE:ANTM) last posted its quarterly earnings data on Wednesday, October 23rd. The company reported $4.87 EPS for the quarter, beating analysts’ consensus estimates of $4.82 by $0.05. The business had revenue of $26.44 billion for the quarter, compared to analyst estimates of $25.88 billion. Anthem had a return on equity of 15.59% and a net margin of 4.29%. The business’s revenue for the quarter was up 15.1% compared to the same quarter last year. During the same quarter last year, the company earned $3.81 earnings per share.
A number of analysts recently commented on ANTM shares. JPMorgan Chase & Co. increased their price objective on Anthem from $322.00 to $391.00 and gave the company an “overweight” rating in a research note on Friday, December 20th. Evercore ISI raised Anthem from an “in-line” rating to an “outperform” rating in a research note on Friday, January 3rd. ValuEngine lowered Anthem from a “hold” rating to a “sell” rating in a research note on Tuesday, January 7th. Mizuho assumed coverage on Anthem in a research note on Thursday, October 17th. They issued a “neutral” rating and a $262.00 price target on the stock. Finally, Credit Suisse Group raised their price target on Anthem from $340.00 to $380.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and twelve have issued a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $330.83.
Shares of ANTM traded down $7.12 during trading hours on Friday, reaching $297.28. 1,088,693 shares of the company traded hands, compared to its average volume of 1,051,380. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 0.60. The stock has a market capitalization of $77.18 billion, a PE ratio of 18.09, a price-to-earnings-growth ratio of 0.85 and a beta of 0.76. Anthem has a fifty-two week low of $227.16 and a fifty-two week high of $317.99. The stock has a fifty day simple moving average of $298.53 and a 200 day simple moving average of $278.46.
In other news, EVP Thomas C. Zielinski sold 10,600 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $288.33, for a total value of $3,056,298.00. Following the transaction, the executive vice president now directly owns 35,247 shares in the company, valued at approximately $10,162,767.51. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Peter D. Haytaian sold 9,586 shares of the firm’s stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $269.57, for a total value of $2,584,098.02. Following the completion of the transaction, the executive vice president now owns 42,488 shares in the company, valued at $11,453,490.16. The disclosure for this sale can be found here. Over the last three months, insiders sold 33,097 shares of company stock worth $9,503,088. 0.17% of the stock is owned by corporate insiders.
Institutional investors have recently added to or reduced their stakes in the company. Sonora Investment Management LLC purchased a new stake in shares of Anthem during the 4th quarter valued at about $30,000. Horan Capital Advisors LLC. purchased a new stake in shares of Anthem during the 3rd quarter valued at about $43,000. Penserra Capital Management LLC purchased a new stake in shares of Anthem during the 3rd quarter valued at about $48,000. Quest Capital Management Inc. ADV purchased a new stake in shares of Anthem during the 3rd quarter valued at about $49,000. Finally, Evoke Wealth LLC purchased a new stake in shares of Anthem during the 3rd quarter valued at about $55,000. Institutional investors own 88.13% of the company’s stock.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Featured Article: Why are percentage decliners important?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.